Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

58%

7 of 12 completed trials have results

Key Signals

3 recruiting7 with results

Enrollment Performance

Analytics

Phase 1
10(66.7%)
N/A
3(20.0%)
Phase 2
2(13.3%)
15Total
Phase 1(10)
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT07423000Phase 1Recruiting

A Phase 1 Study of PVT401 in Healthy Subjects

Role: collaborator

NCT06933043Phase 1Completed

A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults.

Role: collaborator

NCT05979207Phase 1Completed

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Role: collaborator

NCT06891729Not ApplicableCompleted

Plan A Novel Delivery Device Study

Role: collaborator

NCT05114889Phase 1Completed

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Role: collaborator

NCT05287893Phase 1Completed

Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria

Role: collaborator

NCT05605470Phase 2Completed

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Role: collaborator

NCT05205941Phase 1Completed

MMV533 Plasmodium Falciparum Volunteer Infection Study

Role: collaborator

NCT05298306Phase 1Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Role: collaborator

NCT04323306Phase 1Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.

Role: collaborator

NCT05994664Not ApplicableRecruiting

Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients

Role: collaborator

NCT05809323Not ApplicableRecruiting

Marfan Syndrome Moderate Exercise Trial II

Role: collaborator

NCT05272605Phase 1Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

Role: collaborator

NCT04456634Phase 1Completed

Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine

Role: collaborator

NCT03179423Phase 2Completed

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

Role: collaborator

All 15 trials loaded